M518101
Sponsors
Maruho Co., Ltd., Maruho North America Inc., Maruho Europe Limited
Conditions
Healthy VolunteersPlaque PsoriasisPsoriasis
Phase 1
Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients
CompletedNCT01844973
Start: 2013-04-30End: 2013-08-31Updated: 2013-08-19
Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers
CompletedNCT02227069
Start: 2014-09-30End: 2015-03-31Updated: 2015-03-30
Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers
CompletedNCT02256930
Start: 2014-09-30End: 2015-08-31Updated: 2015-08-11
Phase 2
Phase 3
Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis
CompletedNCT01873677
Start: 2013-06-30End: 2015-04-30Updated: 2015-09-02
Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis
CompletedNCT01878461
Start: 2013-06-30End: 2015-05-31Updated: 2015-09-02
Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis
CompletedNCT01908595
Start: 2013-08-31End: 2015-05-31Updated: 2015-09-02
Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients
CompletedNCT01989429
Start: 2013-10-31End: 2014-12-31Updated: 2015-12-31